NCT06318273 2026-02-09A Study to Assess Adverse Events, and How Intravenously (IV) Infused ABBV-969 Moves Through the Bodies of Adult Participants With Metastatic Castration-Resistant Prostate CancerAbbViePhase 1 Recruiting140 enrolled